ArticleFrontiers in oncology2023

CNS efficacy of afatinib as first-line treatment in advanced non-small cell lung cancer patients with EGFR mutations.

Liping Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.